Departamento de Farmácia Galénica e, Tecnologia Farmacêutica, Faculdade de Farmácia da Universidade de Lisboa, Lisboa, Portugal.
Eur J Pharm Biopharm. 2013 Aug;84(3):626-32. doi: 10.1016/j.ejpb.2013.01.004. Epub 2013 Feb 9.
Laminar extrusion of wet masses was studied as a novel technology for the production of dosage forms for oral drug delivery. Extrusion was carried out with a ram extruder. Formulations contained either microcrystalline cellulose (MCC) or dicalcium phosphate (DCP) as diluent, hydroxypropyl methylcellulose (HPMC), lactose, and water. Extrudates were characterized for their tensile strength, Young's modulus of elasticity, water absorption, gel forming capacity, and release of two model drugs, coumarin (COU) and propranolol hydrochloride (PRO). Cohesive extrudates could be produced with both filling materials (MCC and DCP) when HPMC was included as a binder at low amounts (3.3-4.5% w/w dry weight). Employing more HPMC, the elasticity of the wet masses increased which resulted in distinct surface defects. For MCC, the maximum HPMC amount that could be included in the formulations (15% w/w dry weight) did not affect the mechanical properties or decrease the drug release significantly. For DCP extrudates, the maximally effective HPMC amount was 30% (w/w dry weight) with influence on both the mechanical properties and drug release. This study suggests that laminar extrusion of wet masses is a feasible technique for the production of dosage forms for oral drug delivery.
湿物料的层流挤压被研究作为一种生产用于口服药物递送的剂型的新技术。挤压是在柱塞式挤出机中进行的。配方中含有微晶纤维素 (MCC) 或磷酸二钙 (DCP) 作为稀释剂、羟丙基甲基纤维素 (HPMC)、乳糖和水。挤出物的拉伸强度、弹性模量、吸水率、凝胶形成能力以及两种模型药物香豆素 (COU) 和盐酸普萘洛尔 (PRO) 的释放进行了表征。当 HPMC 作为低含量 (3.3-4.5%w/w 干重) 的粘合剂使用时,可以使用两种填充材料 (MCC 和 DCP) 生产粘性挤出物。使用更多的 HPMC,湿物料的弹性增加,导致明显的表面缺陷。对于 MCC,配方中可以包含的最大 HPMC 量 (15%w/w 干重) 不会显著影响机械性能或降低药物释放。对于 DCP 挤出物,最大有效 HPMC 量为 30%(w/w 干重),对机械性能和药物释放都有影响。这项研究表明,湿物料的层流挤压是生产用于口服药物递送的剂型的一种可行技术。